Influenza Hemagglutinin (HA) Peptide: Benchmarks, Mechanism & Experimental Integration

Executive Summary: The Influenza Hemagglutinin (HA) Peptide is a synthetic, nine-amino acid epitope tag (sequence: YPYDVPDYA) derived from the human influenza virus hemagglutinin protein. (1) It enables highly specific detection and purification of HA-tagged proteins via competitive binding to anti-HA antibodies (https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html). (2) The peptide is supplied at >98% purity (HPLC/MS-verified) and demonstrates high solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL) under standard laboratory conditions. (3) HA tags are widely used in immunoprecipitation and protein-protein interaction studies, including applications in E3 ligase and ubiquitination research (https://doi.org/10.1002/advs.202504704). (4) The peptide's efficacy and specificity have been benchmarked against other molecular tags, showing superior compatibility with diverse assay buffers (https://magnetic-co-ip.com/index.php?g=Wap&m=Article&a=detail&id=10760). (5) Proper storage (desiccated, -20°C) ensures maximal stability and performance.

Biological Rationale

The Influenza Hemagglutinin (HA) Peptide functions as a molecular epitope tag for recombinant protein detection and purification. The nine-residue sequence (YPYDVPDYA) is derived from the C-terminal region of the influenza virus hemagglutinin protein, a well-characterized viral glycoprotein mediating host cell entry (NCBI P03437). When genetically fused to a protein of interest, the HA tag enables reproducible recognition by monoclonal anti-HA antibodies due to its minimal immunogenic cross-reactivity and compact size. This strategy supports precise monitoring of protein expression, localization, and interaction dynamics in cellular, biochemical, and translational research workflows. HA tagging is notably valuable in post-translational modification studies, including ubiquitination and protein-protein interaction analysis (Dong et al., 2025).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA tag sequence (YPYDVPDYA) provides a defined linear epitope that binds specifically to anti-HA monoclonal antibodies (e.g., clone 12CA5, 3F10). In immunoprecipitation assays, the synthetic HA peptide (SKU: A6004) is used to competitively displace HA-tagged fusion proteins from antibody complexes, enabling gentle elution. The binding interaction is sequence-specific and reversible. The peptide's high solubility facilitates its use as an elution agent in a range of buffer systems (e.g., PBS, TBS, RIPA) at concentrations up to 100 mg/mL, as confirmed by HPLC and mass spectrometry. The competitive binding mechanism is crucial for high-yield recovery of intact HA fusion proteins without denaturation, which is essential for downstream functional assays. Proper use of the Influenza Hemagglutinin (HA) Peptide ensures minimal background and maximal target protein specificity (ApexBio A6004).

Evidence & Benchmarks

• The HA peptide (YPYDVPDYA) displays >98% purity by HPLC and mass spectrometry, ensuring minimal batch-to-batch variability (ApexBio A6004).
• Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water, measured at 20°C (product documentation).
• HA tag-based immunoprecipitation enables efficient recovery of fusion proteins for protein-protein interaction and ubiquitination studies, as demonstrated in mechanistic research on E3 ligase and PRMT5 interactions (Dong et al., 2025).
• Comparative analyses show that HA tag elution with synthetic peptide preserves protein integrity more effectively than harsh chemical elution or denaturing conditions (Magnetic Co-IP).
• HA peptide tags exhibit minimal immunogenicity and do not interfere with protein folding or localization in most mammalian expression systems (Cy5-Azide).
• Anti-HA antibody-based immunoprecipitation is a cornerstone in translational cancer research, e.g., mapping E3 ligase substrates and their post-translational modifications (Dong et al., 2025).

Applications, Limits & Misconceptions

The HA tag peptide is routinely applied in:

• Immunoprecipitation (IP) and co-immunoprecipitation (Co-IP) workflows for mapping protein-protein interactions.
• Competitive elution of HA-tagged proteins from anti-HA antibody-conjugated beads (magnetic or agarose).
• Detection and quantification of HA-tagged proteins by Western blot, ELISA, and immunofluorescence.
• Functional studies of post-translational modifications, including ubiquitination, phosphorylation, and methylation.
• High-throughput screening, such as shRNA or CRISPR libraries, where tag-based detection is essential (Dong et al., 2025).

For a comprehensive exploration of its translational research value, see Decoding Cellular Signaling in Translational Research, which this article extends by providing granular solubility data and practical workflow guidance.

Common Pitfalls or Misconceptions

• The HA tag does not improve protein solubility; it functions solely as an epitope tag for detection and purification.
• Non-specific binding can occur if antibody specificity is suboptimal or if excessive peptide is used during elution.
• Overexpression of HA-tagged fusion proteins may lead to aggregation or mislocalization in certain expression systems.
• The peptide is not suitable for therapeutic use; it is strictly for research applications.
• Long-term storage of peptide solutions can lead to degradation; always store desiccated at -20°C.

Workflow Integration & Parameters

The Influenza Hemagglutinin (HA) Peptide (A6004) is compatible with a range of immunoprecipitation and purification workflows. For best results, use freshly prepared peptide solutions at 1–2 mg/mL for elution steps. The peptide is stable at room temperature for short durations (<6 hours) but should be stored desiccated at -20°C for long-term preservation. Avoid repeated freeze-thaw cycles. The peptide’s high solubility supports its use in standard buffers (PBS, TBS, RIPA) without precipitation. Elution efficiency is maximized with gentle agitation (15–30 min) at 4°C. For advanced protocol integration, see Precision Epitope Tagging for Interaction Studies; this article updates guidelines with new purity and stability data.

In translational research, HA tag workflows have been pivotal in mapping interactomes and post-translational modification landscapes, e.g., mapping PRMT5 as an E3 ligase substrate (Dong et al., 2025).

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide (A6004) is a validated, high-purity reagent for the detection and purification of HA-tagged proteins. Its robust solubility, competitive binding specificity, and compatibility with antibody-based workflows make it indispensable for protein interaction and ubiquitination studies. As new evidence emerges, including large-scale screens in cancer metastasis models, the HA tag remains a reliable standard for molecular biology (product page). For expanded research applications and workflow comparisons, see Next-Level Precision Tagging, which this article clarifies by adding data-driven storage and handling recommendations. Ongoing refinement of tag-based detection and elution protocols will further enhance reproducibility and sensitivity in complex experimental systems.